Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients With Moderate-to-Severe Plaque Psoriasis: 52-Week Data From the IXORA-S Trial
Norman Wasel, Yves Dutronc, Birgit Schinzel, Jean-Philippe Lacour
Abstract not available.
Disclosures: Study sponsored by Eli Lilly & Company.
Copyright 2018 SKIN
Abstract - 84 Poster PDF - 31
- There are currently no refbacks.